| Financial Year |
March 31 2023 |
| Monetary Funds |
37,960,195,958.77 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,479,882,694.01 |
| Accounts Receivable |
29,312,106,347.19 |
| Advances to Suppliers |
544,917,298.59 |
| Other Receivables |
594,255,497.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
18,875,216,845.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,047,738,568.51 |
| Other Current Assets |
839,745,695.37 |
| Total Current Assets |
95,207,306,822.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
542,461,879.65 |
| Long-term Equity Investment |
1,167,426,208.70 |
| Investment Properties |
-- |
| Fixed Assetes |
9,996,705,843.27 |
| Under-construction Projects |
2,798,969,423.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,685,463,741.07 |
| R&D expenses |
-- |
| Goodwill |
341,424,119.74 |
| Long-Term Deferred and Prepaid Expenses |
175,523,118.72 |
| Deferred Income Tax Assets |
1,536,645,480.92 |
| Other Non-Current Assets |
2,726,235,444.66 |
| Sub-Total of Non-Current Assets |
21,970,418,071.12 |
| Total Assets |
117,177,724,893.23 |
| Short-Term Loans |
2,649,065,150.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,276,078,763.67 |
| Accounts Payable |
11,314,173,986.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,724,869,742.25 |
| Taxes Payable |
1,198,821,878.10 |
| Interest Payable |
-- |
| Dividend Payable |
306,902,088.51 |
| Other payables |
3,170,403,650.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
837,214,836.18 |
| Other Current Liabilities |
867,764,239.34 |
| Sub-Total of Current Liabilities |
26,724,586,952.20 |
| Long-term Loans |
10,674,015,567.53 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,224,573.02 |
| Special Payable |
-- |
| Estimatied Liabilities |
217,105,543.12 |
| Deferred Income Tax Liabilities |
157,219,349.48 |
| Other Non-Current Liabilities |
2,833,280,331.92 |
| Sub-Total of Non-Current Liabilities |
15,092,530,276.47 |
| Total Liabilities |
41,817,117,228.67 |
| Paid-In Capital(Or Share Stock) |
9,363,932,789.00 |
| Capital Surplus |
8,361,756,601.50 |
| Surplus Reserve |
4,715,460,312.00 |
| LESS:Treasury Stock |
3,272,148,424.89 |
| Undistributed Profits |
51,270,057,299.84 |
| Minority Stockholder's Interest |
4,942,629,651.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
70,417,978,013.39 |
| Owner's Equity（Stockholder's Equity） |
75,360,607,664.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
117,177,724,893.23 |
